Edward A. Berger

14.1k total citations · 2 hit papers
116 papers, 10.3k citations indexed

About

Edward A. Berger is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Edward A. Berger has authored 116 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Virology, 49 papers in Immunology and 28 papers in Epidemiology. Recurrent topics in Edward A. Berger's work include HIV Research and Treatment (63 papers), Immune Cell Function and Interaction (35 papers) and HIV/AIDS drug development and treatment (18 papers). Edward A. Berger is often cited by papers focused on HIV Research and Treatment (63 papers), Immune Cell Function and Interaction (35 papers) and HIV/AIDS drug development and treatment (18 papers). Edward A. Berger collaborates with scholars based in United States, Italy and France. Edward A. Berger's co-authors include Philip M. Murphy, Christopher C. Broder, Joshua Μ. Farber, Ghalib Alkhatib, Paul E. Kennedy, Christophe Combadière, Yu Feng, Bernard Moss, Leon Heppel and Paolo Lusso and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Edward A. Berger

113 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1

1996 2.3k citations Ghalib Alkhatib, Yu Feng et al. Science profile →
CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease

1999 1.7k citations Edward A. Berger, Philip M. Murphy et al. profile →

Peers

Countries citing papers authored by Edward A. Berger

Since Specialization

Citations

This map shows the geographic impact of Edward A. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward A. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward A. Berger more than expected).

Fields of papers citing papers by Edward A. Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward A. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward A. Berger. The network helps show where Edward A. Berger may publish in the future.

Co-authorship network of co-authors of Edward A. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Edward A. Berger. A scholar is included among the top collaborators of Edward A. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward A. Berger. Edward A. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Production and Characterization of SIV-Specific CAR/CXCR5 T Cells 2021 ·Methods in molecular biology ·Mary S. Pampusch, Agnes Hajduczki, (unknown), Elizabeth Connick, Edward A. Berger, Pamela J. Skinner	2
2	An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells 2021 ·PLoS ONE ·Yíngyún Caì, Shuǐqìng Yú, Xiǎolì Chī, Sheli R. Radoshitzky, Jens H. Kuhn, Edward A. Berger	4
3	Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort 2016 ·AIDS Research and Human Retroviruses ·Elizabeth Fink, (unknown), Brian K. Agan, Edward A. Berger, Andrew C. S. Saphire, Gerald V. Quinnan, John H. Elder	1
4	Finding Fusin/CXCR4, the First â€œ2nd Receptorâ€ for HIV Entry 2015 ·Frontiers in Immunology ·Edward A. Berger	2
5	Towards a functional cure of HIV Infection using a novel CD4-based chimeric antigen receptor 2014 ·Journal of Antivirals & Antiretrovirals ·Edward A. Berger	1
6	A New Model to Produce Infectious Hepatitis C Virus without the Replication Requirement 2011 ·PLoS Pathogens ·Miriam Triyatni, Edward A. Berger, Bertrand Saunier	14
7	An immunotoxin targeting the gH glycoprotein of KSHV for selective killing of cells in the lytic phase of infection 2011 ·Antiviral Research ·Yíngyún Caì, Edward A. Berger	13
8	Pillars Article: HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein–Coupled Receptor. Science. 1996. 272: 872–877 2011 ·The Journal of Immunology ·Yu Feng, (unknown), Paul E. Kennedy, Edward A. Berger	1
9	Targeted cytotoxic therapy: adapting a rapidly progressing anticancer paradigm for depletion of persistent HIV-infected cell reservoirs 2010 ·Current Opinion in HIV and AIDS ·Edward A. Berger	15
10	Kaposi's Sarcoma-Associated Herpesvirus Fusion-Entry Receptor: Cystine Transporter xCT 2006 ·Science ·Johnan A.R. Kaleeba, Edward A. Berger	132
11	Broad target cell selectivity of Kaposi's sarcoma-associated herpesvirus glycoprotein-mediated cell fusion and virion entry 2006 ·Virology ·Johnan A.R. Kaleeba, Edward A. Berger	22
12	CD46 on glial cells can function as a receptor for viral glycoprotein‐mediated cell–cell fusion 2005 ·Glia ·Riccardo Cassiani‐Ingoni, Heather L. Greenstone, Donatella Donati, Anna Fogdell‐Hahn, Elena Martinelli, Daniel Refai, Roland Martinꝉ, Edward A. Berger, Steven Jacobson	20
13	Interaction of Glycoprotein H of Human Herpesvirus 6 with the Cellular Receptor CD46 2003 ·Journal of Biological Chemistry ·Fabio Santoro, Heather L. Greenstone, Alessandra Insinga, M. Kathryn Liszewski, John Atkinson, Paolo Lusso, Edward A. Berger	58
14	Human Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor Function 2002 ·Journal of Biological Chemistry ·Heather L. Greenstone, Fabio Santoro, Paolo Lusso, Edward A. Berger	52
15	A Human Immunodeficiency Virus–Transgenic Mouse Model for Assessing Interventions that Block Microbial‐Induced Proviral Expression 2001 ·The Journal of Infectious Diseases ·Marco Schito, Paul E. Kennedy, (unknown), Edward A. Berger, Alan Sher	15
16	Introduction: HIV co-receptors solve old questions and raise many new ones 1998 ·Seminars in Immunology ·Edward A. Berger	11
17	CC Chemokine Receptor 5-Mediated Signaling and HIV-1 Co-receptor Activity Share Common Structural Determinants 1997 ·Journal of Biological Chemistry ·Ghalib Alkhatib, Seema S. Ahuja, (unknown), Srinivas Mummidi, Edward A. Berger, Sunil K. Ahuja	63
18	HIV-1 Coreceptor Activity of CCR5 and Its Inhibition by Chemokines: Independence from G Protein Signaling and Importance of Coreceptor Downmodulation 1997 ·Virology ·Ghalib Alkhatib, Massimo Locati, Paul E. Kennedy, Philip M. Murphy, Edward A. Berger	182
19	Recombinant CD4- Pseudomonas Exotoxin Hybrid Protein Displays HIV-Specific Cytotoxicity without Affecting MHC Class II-Dependent Functions 1990 ·AIDS Research and Human Retroviruses ·Edward A. Berger, V K Chaudhary, Kathleen A. Clouse, Dolores Jaraquemada, (unknown), Kathleen L. Rubino, (unknown), Ira Pastan, Bernard Moss	20
20	Complement-fixing antibodies to foods in children. 1953 ·Edward A. Berger	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact